These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17885382)

  • 21. [Genetic markers of predisposition to infectious complications in neonatal infants with respiratory distress syndrome].
    Bogdanova RZ; Tsydenzhapov ETs; Fatykhova AI; Viktorov VV; Viktorova TV; Mironov PI
    Anesteziol Reanimatol; 2009; (1):46-8. PubMed ID: 19348329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
    Wirbelauer J; Thomas W; Speer CP
    Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of evidence for the pharmacological effectiveness of prolonged methylprednisolone treatment in unresolving acute respiratory distress syndrome.
    Meduri GU
    Minerva Anestesiol; 1999 May; 65(5):193-6. PubMed ID: 10389390
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 28. Surfactant respiratory therapy using Surfaxin/sinapultide.
    Lal MK; Sinha SK
    Ther Adv Respir Dis; 2008 Oct; 2(5):339-44. PubMed ID: 19124381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postoperative pulmonary complications in heart surgery--introduction to the concept of lung surfactant].
    Taguchi K; Sasaki N; Matsuura Y
    Kyobu Geka; 1967 Apr; 20(4):246-50. PubMed ID: 4865067
    [No Abstract]   [Full Text] [Related]  

  • 30. Respiratory distress in the newborn.
    Hermansen CL; Lorah KN
    Am Fam Physician; 2007 Oct; 76(7):987-94. PubMed ID: 17956068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Etiology of the respiratory distress syndrome in the newborn].
    Rivard G
    Union Med Can; 1967 Mar; 96(3):269-73. PubMed ID: 5615013
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of respiratory distress syndrome by shake test on newborn gastric aspirate.
    Sutthiwan I; Vaewsorn O; Sutthiwan P
    J Med Assoc Thai; 1980 Feb; 63(2):87-90. PubMed ID: 7365347
    [No Abstract]   [Full Text] [Related]  

  • 34. Need to avoid bias in controlled trials.
    Logan S
    Arch Dis Child Fetal Neonatal Ed; 1995 Sep; 73(2):F121. PubMed ID: 7583599
    [No Abstract]   [Full Text] [Related]  

  • 35. Perfluorocarbons in the treatment of respiratory distress syndrome.
    Jacobs HC; Mercurio MR
    Semin Perinatol; 1993 Aug; 17(4):295-302. PubMed ID: 8140444
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nursing aspects in the treatment of respiratory distress syndrome].
    Meyer A; Günther S
    Kinderkrankenschwester; 1995 Mar; 14(3):115-6. PubMed ID: 7703162
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary surfactant administration in neonates with respiratory decompensation.
    Bissinger R; Carlson C; Michel Y; Dooley C; Hulsey T; Jenkins D
    J Perinatol; 2008 Mar; 28(3):192-8. PubMed ID: 18235534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical symptoms and biochemical changes in the respiratory distress syndrome].
    Mentzel H
    Dtsch Med J; 1970 Mar; 21(5):261-3. PubMed ID: 5436894
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early administration of surfactant in spontaneous breathing with nCPAP through a thin endotracheal catheter--an option in the treatment of RDS in ELBW infants?
    Kribs A
    J Perinatol; 2009 Mar; 29(3):256. PubMed ID: 19240733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.